Global Acute Myeloid Leukemia (AML) Therapeutics Strategic Research Report 2023: Market to Reach $1.6 Billion by 2030 with Cytarabine Accounting for $571.6 Million
December 05, 2023 10:48 ET
|
Research and Markets
Dublin, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Acute...
Global Acute Myeloid Leukemia (AML) Treatment Market Report 2023-2028A $3.5 Billion Market by 2022 - Anthracycline Drugs and Chemotherapies Make Their Mark in AML Treatment
October 19, 2023 04:18 ET
|
Research and Markets
Dublin, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends" report has been added to ResearchAndMarkets.com's offering.The global AML...
Global Acute Myeloid Leukemia (AML) Therapeutics Market Report 2021: Market to Reach $976.2 Billion by 2026 - Emerging Drug Therapies/Targeted Therapies to Drive Future Growth
December 06, 2021 03:38 ET
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering....
Acute Myeloid Leukemia (AML) Market Insights & Epidemiology Analysis & Forecasts, 2018-2020 & 2021-2030: Major Markets, Marketed Therapies, Emerging Therapies, Case Reports, Patient Journey
August 05, 2021 07:28 ET
|
Research and Markets
Dublin, Aug. 05, 2021 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML)- Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. The...